ENTOD Pharmaceuticals has announced the appointment of Balasubramanian K Pillai as its new Chief Financial Officer (CFO). With an impressive career spanning over 26 years in financial planning, risk management, and business growth, Pillai is set to lead the company’s financial strategy and support its expansion efforts.
Pillai brings extensive leadership experience from renowned organizations, including Reliance Group, Globacom Africa, Petroleum Development of Oman, and Akums Group. His diverse industry expertise covers telecom, technology, education, pharmaceuticals, and manufacturing across key global regions such as India, MENA, Europe, and Africa.
A Chartered Accountant, Pillai holds a First-Class Postgraduate Degree from the University of Pune, an LLB from the University of Mumbai, and an SMP from IIM Calcutta. He is also a Certified Information Systems Auditor (CISA) from ISACA, USA.
